Banook Acquires Fluidda to Expand into Respiratory Clinical Research

Schoenherr has advised FRI-Invest GmbH and its shareholders. The acquisition of Fluidda by Banook represents a significant transaction in the healthcare and technology sectors, with FRI-Invest…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Maha Kanaan

Author: Maha Kanaan

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here